3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
18
Gastrointestinal Stromal Tumors
10
Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
4
Kidney Neoplasms
4
Urologic Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Diseases
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
Fluorouracil
16
Oxaliplatin
14
Nivolumab
14
Leucovorin
13
pembrolizumab
9
Paclitaxel
9
Capecitabine
9
Radiotherapy
6
Radiation
6
durvalumab
5
Taxes
5
Irinotecan
5
Cisplatin
5
Trastuzumab
4
Specimen Handling
4
Drug Therapy
4
Carboplatin
4
tremelimumab
3
dehydroftorafur
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Folfox protocol
3
Endoscopy
3
Docetaxel
3
Biopsy
3
zimberelimab
2
zanidatamab
2
trastuzumab deruxtecan
2
tislelizumab
2
futibatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Sunitinib
×
1 year
×
Clear all
No trials found.